Showing results (91-100 of 369) with videos related to
Sort By:
Pageof 37
Basic & Clinical Pharmacology & Toxicology|April 24, 2007
Effects of subchronic lithium treatment on levels of BDNF, Bcl-2 and phospho-CREB in the rat hippocampusMichael D Hammonds, Seong S Shim, Pingfu Feng, et al.AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 23, 2023
Comprehensive Analysis of Electronic Health Records to Characterize The Association Between Intimate Partner Violence and Mental HealthGünnur Karakurt, Serhan Yılmaz, Meera Kumari, et al.Psychosomatics|August 14, 2017
Nonconvulsive Status Epilepticus After Electroconvulsive Therapy: A Review of LiteratureAwais Aftab, Ashley VanDercar, Ayham Alkhachroum, et al.Neuropsychiatric Disease and Treatment|September 5, 2013
Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorderKeming Gao, Mary Mackle, Pilar Cazorla, et al.Journal of Affective Disorders|July 13, 2019
Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictorsVicki C Fung, Lindsay N Overhage, Louisa G Sylvia, et al.Expert Opinion on Drug Safety|June 18, 2019
Comparison of common side effects from mood stabilizers and antipsychotics between pediatric and adult patients with bipolar disorder: a systematic review of randomized, double-blind, placebo-controlled trialsYuanhan Bai, Tiebang Liu, Ahong Xu, et al.Journal of the Academy of Consultation-Liaison Psychiatry|September 10, 2021
Associations Among Irritability, High-Sensitivity C-Reactive Protein/Interleukin-6, and Depression in Patients With Early-Stage Breast Cancer Undergoing Chemotherapy: A Prospective StudyAmy Y Zhang, Stephen J Ganocy, Cynthia Owusu, et al.Psychiatric Services (Washington, D.C.)|June 25, 2025
Racial-Ethnic Disparities in Ketamine and Esketamine Therapy for Major Depressive DisorderMichael Liu, Rachel Branning, Austin Lee, et al.Psychopharmacology Bulletin|April 14, 2025
Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to AdulthoodKeming Gao, Buket Koparal, Evrim Bayrak Oruc, et al.The Australian and New Zealand Journal of Psychiatry|November 17, 2017
Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depressionMarco Antonio Caldieraro, Samantha Walsh, Thilo Deckersbach, et al.Pageof 37